The Chemours Company Reports Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Chemours (CC) PT Lowered to $20 at Jefferies
February 19, 2025 5:43 AM ESTJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $20.00 (from $21.00) while maintaining a Hold rating.
The analyst comments "Q4 EBITDA of $179 was $14m above both consensus and our estimate. 2025 EBITDA is pegged at $825-$975m (consensus... More
